4//SEC Filing
ROTE WILLIAM E. 4
Accession 0001415889-24-001800
CIK 0001438533other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:10 PM ET
Size
5.4 KB
Accession
0001415889-24-001800
Insider Transaction Report
Form 4
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Transactions
- Sale
Common Stock
2024-01-23$8.96/sh−2,062$18,476→ 60,484 total
Footnotes (2)
- [F1]This sale was made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F2]Includes 1,373 shares of the Issuer's common stock acquired by the reporting person on November 30, 2023 pursuant to an employee stock purchase program.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001698262
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:10 PM ET
- Size
- 5.4 KB